淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4824人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1998010, encodeId=7bef1998010a0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率, objectType=article, longId=207858, objectId=4adc20e8585b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4adc20e8585b, replyNumber=0, likeNumber=67, createdTime=2021-12-23, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4adc20e8585b, moduleTitle=JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4adc20e8585b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998003, encodeId=e83119980035c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：慢性淋巴细胞白血病Richter转化的基因组和转录组学特征, objectType=article, longId=204876, objectId=87c52048e692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87c52048e692, replyNumber=0, likeNumber=97, createdTime=2021-01-30, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87c52048e692, moduleTitle=Blood：慢性淋巴细胞白血病Richter转化的基因组和转录组学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87c52048e692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998009, encodeId=fba3199800956, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=JAMA：Blinatumomab vs 化疗用于首次复发的B细胞急性淋巴细胞白血病儿童、青少年和年轻患者, objectType=article, longId=207857, objectId=663420e857ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=663420e857ae, replyNumber=0, likeNumber=76, createdTime=2021-04-13, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=663420e857ae, moduleTitle=JAMA：Blinatumomab vs 化疗用于首次复发的B细胞急性淋巴细胞白血病儿童、青少年和年轻患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=663420e857ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997991, encodeId=443b199e99101, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗, objectType=article, longId=201430, objectId=394e2014304d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=394e2014304d, replyNumber=0, likeNumber=133, createdTime=2021-03-18, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=394e2014304d, moduleTitle=J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=394e2014304d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997996, encodeId=3f29199e9969c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=CD20单抗Ublituximab与PI3K抑制剂Umbralisib联合治疗慢性淋巴细胞白血病，获FDA快速通道指定, objectType=article, longId=202384, objectId=f40b202384ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f40b202384ce, replyNumber=0, likeNumber=80, createdTime=2021-07-30, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f40b202384ce, moduleTitle=CD20单抗Ublituximab与PI3K抑制剂Umbralisib联合治疗慢性淋巴细胞白血病，获FDA快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f40b202384ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997997, encodeId=eea4199e997c3, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NEJM：达沙替尼-博纳吐单抗治疗费城染色体阳性急性淋巴细胞白血病, objectType=article, longId=202407, objectId=564a20240ecb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=564a20240ecb, replyNumber=0, likeNumber=94, createdTime=2020-10-31, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=564a20240ecb, moduleTitle=NEJM：达沙替尼-博纳吐单抗治疗费城染色体阳性急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=564a20240ecb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997994, encodeId=e00b199e9949f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：急性淋巴细胞白血病婴儿的风险分层治疗, objectType=article, longId=202236, objectId=db7b2022363e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db7b2022363e, replyNumber=0, likeNumber=97, createdTime=2020-12-11, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db7b2022363e, moduleTitle=Blood：急性淋巴细胞白血病婴儿的风险分层治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db7b2022363e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997995, encodeId=c962199e995fc, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：奥英妥珠单抗（InO）治疗儿童复发性/难治性CD22阳性急性淋巴细胞白血病, objectType=article, longId=202315, objectId=efc2202315cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efc2202315cb, replyNumber=0, likeNumber=74, createdTime=2021-07-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efc2202315cb, moduleTitle=Blood：奥英妥珠单抗（InO）治疗儿童复发性/难治性CD22阳性急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efc2202315cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997990, encodeId=dd21199e990a4, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=亚盛医药Bcl-2抑制剂再获FDA孤儿药资格认定，治疗慢性淋巴细胞白血病, objectType=article, longId=200423, objectId=5feb2004238f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5feb2004238f, replyNumber=0, likeNumber=89, createdTime=2021-01-14, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5feb2004238f, moduleTitle=亚盛医药Bcl-2抑制剂再获FDA孤儿药资格认定，治疗慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5feb2004238f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997984, encodeId=fa2d199e984d8, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, objectType=article, longId=194212, objectId=13c2194212aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c2194212aa, replyNumber=0, likeNumber=73, createdTime=2021-04-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c2194212aa, moduleTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13c2194212aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998000, encodeId=a65d1998000d8, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NICE支持Calquence（acalabrutinib）治疗慢性淋巴细胞白血病, objectType=article, longId=204332, objectId=25ac2043325e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25ac2043325e, replyNumber=0, likeNumber=95, createdTime=2021-07-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25ac2043325e, moduleTitle=NICE支持Calquence（acalabrutinib）治疗慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25ac2043325e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997981, encodeId=f539199e981c4, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet：Acalabrutinib一线治疗慢性淋巴细胞白血病效果显著, objectType=article, longId=192479, objectId=9a741924e989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a741924e989, replyNumber=0, likeNumber=77, createdTime=2020-07-24, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a741924e989, moduleTitle=Lancet：Acalabrutinib一线治疗慢性淋巴细胞白血病效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a741924e989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997987, encodeId=ae19199e98746, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：急性淋巴细胞白血病的风险分层适应性疗法, objectType=article, longId=197648, objectId=5c1419e648ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c1419e648ca, replyNumber=0, likeNumber=67, createdTime=2020-09-23, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c1419e648ca, moduleTitle=Blood：急性淋巴细胞白血病的风险分层适应性疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c1419e648ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997976, encodeId=e9e3199e97621, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=BCL-2抑制剂VENCLYXTO与CD20单抗obinutuzumab的联合疗法获欧洲批准，用于未经治疗的慢性淋巴细胞白血病, objectType=article, longId=190017, objectId=0f0519001e6d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f0519001e6d, replyNumber=0, likeNumber=76, createdTime=2021-01-25, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f0519001e6d, moduleTitle=BCL-2抑制剂VENCLYXTO与CD20单抗obinutuzumab的联合疗法获欧洲批准，用于未经治疗的慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f0519001e6d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997985, encodeId=597d199e98502, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解, objectType=article, longId=195407, objectId=8e5719540e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e5719540e54, replyNumber=0, likeNumber=77, createdTime=2020-06-23, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e5719540e54, moduleTitle=CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e5719540e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997989, encodeId=2870199e9897c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Leuk Res：伊诺珠单抗治疗复发/难治性急性淋巴细胞白血病患者最小残留疾病的效果, objectType=article, longId=199437, objectId=1a9d19943e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a9d19943e0e, replyNumber=0, likeNumber=86, createdTime=2020-10-10, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a9d19943e0e, moduleTitle=Leuk Res：伊诺珠单抗治疗复发/难治性急性淋巴细胞白血病患者最小残留疾病的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a9d19943e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997966, encodeId=3896199e966b2, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=ASH2019：外周血白血病负荷对难治/复发急性B淋巴细胞白血病CD19-CART细胞培养及临床疗效的影响, objectType=article, longId=184476, objectId=09e41844e696, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09e41844e696, replyNumber=0, likeNumber=87, createdTime=2019-12-25, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09e41844e696, moduleTitle=ASH2019：外周血白血病负荷对难治/复发急性B淋巴细胞白血病CD19-CART细胞培养及临床疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09e41844e696)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997983, encodeId=b82f199e98378, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布, objectType=article, longId=193184, objectId=fb6d193184c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb6d193184c5, replyNumber=0, likeNumber=66, createdTime=2021-01-19, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6d193184c5, moduleTitle=AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6d193184c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997968, encodeId=1ac4199e96887, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V4）, objectType=article, longId=185478, objectId=a93e1854e8e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a93e1854e8e8, replyNumber=0, likeNumber=36, createdTime=2020-01-31, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a93e1854e8e8, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a93e1854e8e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997982, encodeId=7ce6199e98282, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：在急性淋巴细胞白血病中，E2A-PBX1是RUNX1的辅激活因子, objectType=article, longId=192538, objectId=a333192538d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a333192538d4, replyNumber=0, likeNumber=78, createdTime=2020-10-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a333192538d4, moduleTitle=Blood：在急性淋巴细胞白血病中，E2A-PBX1是RUNX1的辅激活因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a333192538d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率

2021-12-23

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：慢性淋巴细胞白血病Richter转化的基因组和转录组学特征

2021-01-30

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

JAMA：Blinatumomab vs 化疗用于首次复发的B细胞急性淋巴细胞白血病儿童、青少年和年轻患者

2021-04-13

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗

2021-03-18

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

CD20单抗Ublituximab与PI3K抑制剂Umbralisib联合治疗慢性淋巴细胞白血病，获FDA快速通道指定

2021-07-30

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NEJM：达沙替尼-博纳吐单抗治疗费城染色体阳性急性淋巴细胞白血病

2020-10-31

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：急性淋巴细胞白血病婴儿的风险分层治疗

2020-12-11

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：奥英妥珠单抗（InO）治疗儿童复发性/难治性CD22阳性急性淋巴细胞白血病

2021-07-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

亚盛医药Bcl-2抑制剂再获FDA孤儿药资格认定，治疗慢性淋巴细胞白血病

2021-01-14

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知

2021-04-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NICE支持Calquence（acalabrutinib）治疗慢性淋巴细胞白血病

2021-07-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet：Acalabrutinib一线治疗慢性淋巴细胞白血病效果显著

2020-07-24

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：急性淋巴细胞白血病的风险分层适应性疗法

2020-09-23

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

BCL-2抑制剂VENCLYXTO与CD20单抗obinutuzumab的联合疗法获欧洲批准，用于未经治疗的慢性淋巴细胞白血病

2021-01-25

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解

2020-06-23

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Leuk Res：伊诺珠单抗治疗复发/难治性急性淋巴细胞白血病患者最小残留疾病的效果

2020-10-10

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

ASH2019：外周血白血病负荷对难治/复发急性B淋巴细胞白血病CD19-CART细胞培养及临床疗效的影响

2019-12-25

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布

2021-01-19

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V4）

2020-01-31

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：在急性淋巴细胞白血病中，E2A-PBX1是RUNX1的辅激活因子

2020-10-07

科室
- - 订阅+
  - 更多科室
工具
服务